International Stereotactic Radiosurgery Society (ISRS)’s Post

European Society for Radiotherapy and Oncology (ESTRO) #ESTRO24 utilized a theme of "Radiation Oncology: Bridging the Care Gap." If you were in attendance what were some key takeaways? Those of you in #RadOnc, what are some gaps that you recognize in the field? Solutions? #medphys #ESTRO2024 #medicalphysics #cancercare #radiationoncology

🎉 Excited to share our latest publication in Oral Oncology! 📚 🔗 Find the link in the comments below. Our prospective study involved 102 patients treated with radiotherapy for head and neck cancer at Institut Godinot in Reims. We did not find any association between smoking during radiotherapy and the occurrence of severe acute toxicities. 👏 Thanks and bravo to the principal investigator of this study, Camille Invernizzi, António Da Silva Ribeiro Mota, and Esteban Brenet! #OralOncology #CancerResearch #HeadAndNeckCancer #Radiotherapy #ClinicalResearch

📢 New from Lancet Oncology: An assessment of global access to radiotherapy & theranostics! 🌍 Disparities remain, yet strides have been made since 2015. Read more here: https://lnkd.in/gM9pTPPZ

My personal AUA Highlight of the day ADJUVANT OR EARLY SALVAGE RADIOTHERAPY IN NODE POSITIVE PROSTATE CANCER PATIENTS: DEVELOPMENT OF A NOVEL RISK SCORE TO IDENTIFY THE OPTIMAL CANDIDATE FOR EARLY INTENSIFICATION APPROACHES BASED ON A LARGE, MULTI-INSTITUTIONAL SERIES

#PaperoftheDay: "WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?" DOI ⬇️ https://lnkd.in/eF7gkSZm #medulloblastoma #cancer #research #openaccess #peerreview #publishing

The authors focus on the role of surgical resection for small bowel neuroendocrine tumors (SB-NETs) in this Annals of Surgical Oncology #FeaturedArticle. 📃: https://lnkd.in/e9PRyAg

Induction bevacizumab, cisplatin, and etoposide (BEEP) preceding whole-brain radiotherapy (WBRT) improved brain-specific progression-free survival as compared to WBRT alone in metastatic breast cancer patients with brain metastasis irrespective of subtypes. https://ja.ma/3GTdeJS

Nothing triggers my imposter syndrome more than planning post-operative radiotherapy for thymoma! As mentioned in a previous post, it really is an art - and like all art, it’s subjective. However, two key papers help reassure me. The work of Florit Marcuse highlights the importance of collaborative working, while Andreas Rimner's research shows that in experienced hands, post-operative radiotherapy for thymoma does a good job! In-field recurrences are rare (as I see in my own practice). When it comes to rare cancers like thymoma, selecting a radiation oncologist who treats patients with this condition regularly is essential. Repetition builds pattern recognition, making something rare routine. #oncology #radiationtherapy #thymoma #rarecancer #impostersyndrome Marcuse F et al. Radiotherapy and Oncology. 2021;165:8-13 Rimner A et al. Journal of Thoracic Oncology. 2014;9(3):403-9

Please join us at Icotec for this very informative webinar on the utilization of carbon PEEK in spine oncology radiation therapy planning #radiationoncology#dosimetry#carbonfiberPEEK#blackarmor

Great to see these recommendations now available to assist informed practice on radiotherapy alongside new and more frequently used systemic treatments. #radiotherapy #breastcancer #immunotherapy